SCHEMBL6432602

SCHEMBL6432602

CCOP(=O)(COCc1ccc(NC(=O)/C=C/c2cnn(C)c2-c2ccc(F)cc2)cc1)OCC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNC P24863 7/20 0.39
CDK8 P49336 7/20 0.39
CDK19 Q9BWU1 2/20 0.39
NAMPT P43490 1/20 0.39
GRM5 P41594 1/20 0.36
MMP1 P03956 3/20 0.36
MMP2 P08253 3/20 0.36
MMP9 P14780 3/20 0.36
LMNA P02545 2/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
LRRK2 Q5S007 1/20 0.34
EGFR P00533 1/20 0.34
HPSE Q9Y251 2/20 0.34
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
HPGD P15428 1/20 0.34
GFER P55789 1/20 0.34
HTR2A P28223 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4829084 0.90 BTK (0.41) CCNCCDK8CDK19GRM5MMP1
SCHEMBL1060125 0.90 BTK (0.41) CCNCCDK8CDK19GRM5MMP1
SCHEMBL4834146 0.88 CCNC (0.44) CCNCCDK8CDK19GRM5MMP1
SCHEMBL4834135 0.88 CCNC (0.44) CCNCCDK8CDK19GRM5MMP1
SCHEMBL3486742 0.86 CCNC (0.42) CCNCCDK8CDK19NAMPTGRM5
SCHEMBL3486740 0.86 CCNC (0.42) CCNCCDK8CDK19NAMPTGRM5
SCHEMBL4825717 0.85 NPC1 (0.39) CCNCCDK8CDK19GRM5MMP1
SCHEMBL4825720 0.85 NPC1 (0.39) CCNCCDK8CDK19GRM5MMP1
SCHEMBL4831228 0.84 CCNC (0.45) CCNCCDK8CDK19NAMPTMMP1
SCHEMBL4831246 0.84 CCNC (0.45) CCNCCDK8CDK19NAMPTMMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1556032-A1 AGENT FOR PREVENTING OR TREATING NEUROPATHY Takeda Pharmaceutical Company Limited (JP) 2005-07-27 EP disclosed
WO-2004039365-A1 AGENT FOR PREVENTING OR TREATING NEUROPATHY TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-05-13 WO disclosed